Terms: = Skin cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED
62 results:
1. Ceftriaxone exerts antitumor effects in mycn-driven retinoblastoma and neuroblastoma by targeting DDX3X for translation repression.
Chittavanich P; Saengwimol D; Roytrakul S; Rojanaporn D; Chaitankar V; Srimongkol A; Anurathapan U; Hongeng S; Kaewkhaw R
Mol Oncol; 2024 Apr; 18(4):918-938. PubMed ID: 37975412
[TBL] [Abstract] [Full Text] [Related]
2. Whole-exome sequencing of secondary tumors arising from nevus sebaceous revealed additional genomic alterations besides RAS mutations.
Kim YS; Park GS; Chung YJ; Lee JH
J Dermatol; 2023 Aug; 50(8):1072-1075. PubMed ID: 36938660
[TBL] [Abstract] [Full Text] [Related]
3. Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids.
Srimongkol A; Laosillapacharoen N; Saengwimol D; Chaitankar V; Rojanaporn D; Thanomchard T; Borwornpinyo S; Hongeng S; Kaewkhaw R
J Exp Clin Cancer Res; 2023 Feb; 42(1):39. PubMed ID: 36726110
[TBL] [Abstract] [Full Text] [Related]
4. Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease.
Trieu KG; Tsai SY; Eberl M; Ju V; Ford NC; Doane OJ; Peterson JK; Veniaminova NA; Grachtchouk M; Harms PW; Swartling FJ; Dlugosz AA; Wong SY
Cell Rep; 2022 May; 39(5):110779. PubMed ID: 35508126
[TBL] [Abstract] [Full Text] [Related]
5. Infantile Stage M Neuroblastoma With 11q Deletion, Mimicking Stage MS.
Yoshimoto Suzuki Y; Yamanaka J; Miyazaki O; Nozawa K; Ohira M; Kamijo T; Shichino H
J Pediatr Hematol Oncol; 2022 Apr; 44(3):e779-e781. PubMed ID: 35001057
[TBL] [Abstract] [Full Text] [Related]
6. Transcriptomic changes during stage progression of mycosis fungoides.
Xiao MZX; Hennessey D; Iyer A; O'Keefe S; Zhang F; Sivanand A; Gniadecki R
Br J Dermatol; 2022 Mar; 186(3):520-531. PubMed ID: 34528236
[TBL] [Abstract] [Full Text] [Related]
7. MYC oncogene is associated with suppression of tumor immunity and targeting Myc induces tumor cell immunogenicity for therapeutic whole cell vaccination.
Wu X; Nelson M; Basu M; Srinivasan P; Lazarski C; Zhang P; Zheng P; Sandler AD
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33757986
[TBL] [Abstract] [Full Text] [Related]
8. Silencing of the Long Noncoding RNA mycnOS1 Suppresses Activity of mycn-Amplified Retinoblastoma Without RB1 Mutation.
Saengwimol D; Chittavanich P; Laosillapacharoen N; Srimongkol A; Chaitankar V; Rojanaporn D; Aroonroch R; Suktitipat B; Saisawang C; Svasti S; Hongeng S; Kaewkhaw R
Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):8. PubMed ID: 33270844
[TBL] [Abstract] [Full Text] [Related]
9. Characterizing therapeutic signatures of transcription factors in cancer by incorporating profiles in compound treated cells.
Jung J
Bioinformatics; 2021 May; 37(7):1008-1014. PubMed ID: 32886093
[TBL] [Abstract] [Full Text] [Related]
10. Neuroblastoma in a Neonate: A Case Report.
Jnah AJ; Evans SK; Sewell K; Trembath A
Neonatal Netw; 2019 Nov; 38(6):341-347. PubMed ID: 31712398
[TBL] [Abstract] [Full Text] [Related]
11. Merkel Cell Polyomavirus Downregulates n-myc Downstream-Regulated Gene 1, Leading to Cellular Proliferation and Migration.
Gupta P; Shahzad N; Harold A; Shuda M; Venuti A; Romero-Medina MC; Pacini L; Brault L; Robitaille A; Taverniti V; Hernandez-Vargas H; Durand G; Le Calvez-Kelm F; Gheit T; Accardi R; Tommasino M
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694959
[TBL] [Abstract] [Full Text] [Related]
12. [Clinical characteristics and prognosis of high-risk neuroblastoma with bone marrow metastasis in children].
Fan HJ; Huang C; Su Y; Wang XD; Zhou YC; Duan C; Zhao W; Zhao Q; Jin M; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Nov; 57(11):863-869. PubMed ID: 31665841
[No Abstract] [Full Text] [Related]
13. Hypoxic Gene Signature of Primary and Metastatic Melanoma Cell Lines: Focusing on HIF-1β and NDRG-1.
Ercin ME; Bozdoğan Ö; Çavuşoğlu T; Bozdoğan N; Atasoy P; Koçak M
Balkan Med J; 2019 Dec; 37(1):15-23. PubMed ID: 31594284
[TBL] [Abstract] [Full Text] [Related]
14. Expression of n-myc, NAMPT and SIRT1 in Basal Cell Carcinomas and their Cells of Origin.
Brandl L; Hartmann D; Kirchner T; Menssen A
Acta Derm Venereol; 2019 Jan; 99(1):63-71. PubMed ID: 30182136
[TBL] [Abstract] [Full Text] [Related]
15. Understanding the Molecular Genetics of Basal Cell Carcinoma.
Pellegrini C; Maturo MG; Di Nardo L; Ciciarelli V; Gutiérrez García-Rodrigo C; Fargnoli MC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165358
[TBL] [Abstract] [Full Text] [Related]
16. Merkel Cell Polyomavirus Small T Antigen Promotes Pro-Glycolytic Metabolic Perturbations Required for Transformation.
Berrios C; Padi M; Keibler MA; Park DE; Molla V; Cheng J; Lee SM; Stephanopoulos G; Quackenbush J; DeCaprio JA
PLoS Pathog; 2016 Nov; 12(11):e1006020. PubMed ID: 27880818
[TBL] [Abstract] [Full Text] [Related]
17. Expanding the Genetic Profile of BCC.
Cancer Discov; 2016 May; 6(5):OF2. PubMed ID: 27006369
[TBL] [Abstract] [Full Text] [Related]
18. Updates on the Molecular Pathology of Selected Ocular and Ocular Adnexal Tumors: Potential Targets for Future Therapy.
Stagner AM; Jakobiec FA
Semin Ophthalmol; 2016; 31(1-2):188-96. PubMed ID: 26959146
[TBL] [Abstract] [Full Text] [Related]
19. Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma.
Bonilla X; Parmentier L; King B; Bezrukov F; Kaya G; Zoete V; Seplyarskiy VB; Sharpe HJ; McKee T; Letourneau A; Ribaux PG; Popadin K; Basset-Seguin N; Ben Chaabene R; Santoni FA; Andrianova MA; Guipponi M; Garieri M; Verdan C; Grosdemange K; Sumara O; Eilers M; Aifantis I; Michielin O; de Sauvage FJ; Antonarakis SE; Nikolaev SI
Nat Genet; 2016 Apr; 48(4):398-406. PubMed ID: 26950094
[TBL] [Abstract] [Full Text] [Related]
20. Interactions between Myc and MondoA transcription factors in metabolism and tumourigenesis.
Wilde BR; Ayer DE
Br J Cancer; 2015 Dec; 113(11):1529-33. PubMed ID: 26469830
[TBL] [Abstract] [Full Text] [Related]
[Next]
